Thermo Fisher Scientific Inc. (TMO) Free Cash Flow (FCF): $6.29B
The free cash flow (FCF) for Thermo Fisher Scientific Inc. (TMO) is $6.29B. It is below its 12-month average by 7.18% ($6.78B).
TMO Free Cash Flow (FCF) Chart
TMO Average Free Cash Flow (FCF) Chart
TMO Current vs Average Free Cash Flow (FCF) Chart
TMO Free Cash Flow (FCF) Metrics
FREE CASH FLOW (FCF)
$6.29B
FREE CASH FLOW (FCF) AVG TTM
$6.78B
FREE CASH FLOW (FCF) AVG 3Y
$6.85B
FREE CASH FLOW (FCF) AVG 5Y
$6.87B
FREE CASH FLOW (FCF) AVG 10Y
$5.24B
FREE CASH FLOW (FCF) AVG 15Y
$4.12B
FREE CASH FLOW (FCF) AVG 20Y
$3.35B
CURRENT VS TTM AVG
-7.18%
CURRENT VS 3Y AVG
-8.12%
CURRENT VS 5Y AVG
-8.43%
CURRENT VS 10Y AVG
+20.04%
CURRENT VS 15Y AVG
+52.63%
CURRENT VS 20Y AVG
+87.61%
FCF Analysis
Free Cash Flow (TTM)
$6.29B
FCF Yield
3.75%
Price/FCF
26.7
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
- Shows actual cash available (not accounting earnings)
- Funds dividends, buybacks, and debt reduction
- Less susceptible to accounting manipulation than net income
- Key metric for DCF valuation models
Thermo Fisher Scientific Inc. Free Cash Flow (FCF) Formula & Definition
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Thermo Fisher Scientific Inc. Free Cash Flow (FCF) FAQ
- What is the free cash flow (FCF) for Thermo Fisher Scientific Inc. (TMO)?
- The free cash flow (FCF) for TMO stock is $6.29B.
- What is the TTM average free cash flow (FCF) for Thermo Fisher Scientific Inc. (TMO)?
- The TTM average free cash flow (FCF) for TMO stock is $6.78B.
- What is the 3Y average free cash flow (FCF) for Thermo Fisher Scientific Inc. (TMO)?
- The 3Y average free cash flow (FCF) for TMO stock is $6.85B.
- What is the 5Y average free cash flow (FCF) for Thermo Fisher Scientific Inc. (TMO)?
- The 5Y average free cash flow (FCF) for TMO stock is $6.87B.
- What is the 10Y average free cash flow (FCF) for Thermo Fisher Scientific Inc. (TMO)?
- The 10Y average free cash flow (FCF) for TMO stock is $5.24B.
- What is the 15Y average free cash flow (FCF) for Thermo Fisher Scientific Inc. (TMO)?
- The 15Y average free cash flow (FCF) for TMO stock is $4.12B.
- What is the 20Y average free cash flow (FCF) for Thermo Fisher Scientific Inc. (TMO)?
- The 20Y average free cash flow (FCF) for TMO stock is $3.35B.
Thermo Fisher Scientific Inc. Free Cash Flow (FCF) History
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2025-12-31 | $6.29B |
| 2024-12-31 | $7.27B |
| 2023-12-31 | $6.93B |
| 2022-12-31 | $6.91B |
| 2021-12-31 | $7.02B |
| 2020-12-31 | $6.82B |
| 2019-12-31 | $4.05B |
| 2018-12-31 | $3.79B |
| 2017-12-31 | $3.50B |
| 2016-12-31 | $2.71B |
| 2015-12-31 | $2.39B |
| 2014-12-31 | $2.19B |
| 2013-12-31 | $1.73B |
| 2012-12-31 | $1.72B |
| 2011-12-31 | $1.42B |
| 2010-12-31 | $1.23B |
| 2009-12-31 | $1.45B |
| 2008-12-31 | $1.16B |
| 2007-12-31 | $1.31B |
| 2006-12-31 | $328.86M |
| 2005-12-31 | $227.37M |
| 2004-12-31 | $214.53M |
| 2003-12-31 | $170.58M |
| 2002-12-31 | $51.68M |
| 2001-12-31 | $103.60M |
| 2000-12-31 | $125.88M |
| 1999-12-31 | $-150.88M |
| 1998-12-31 | $-72.70M |
| 1997-12-31 | $-691.70M |
| 1996-12-31 | $100.00M |
Related Metrics
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Marc N. Casper